582 Companies
London-based preclinical biopharmaceutical firm TOKYO Pharma Limited has made significant strides in the development of therapeutics targeted at managing and treating inflammatory eye diseases and ...
OKYO Pharma Limited Annual Report 2021I-Mab Breaks Ground in Biopharmaceutical Industry Shanghai-based I-Mab, a clinical stage biopharmaceutical company, has been making waves in the field with its cutting-edge research in cancer and ...
I-MAB Annual Report 2023Clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. is dedicated to the development of therapies for treating liver and chronic diseases. Its lead product candidate, seladelpar (MBX...
CymaBay Therapeutics Annual Report 2023Austin-based Savara Inc., a clinical stage biopharmaceutical firm, is zeroing in on rare respiratory diseases with its innovative approach. The company's frontrunner is its star candidate, molgramo...
Savara Pharmaceuticals Annual Report 2023Champions Oncology, Inc. is leading the way in personalized cancer care with its innovative Tumorgraft Technology Platform. This platform involves implanting human tumors in immune-deficient mice a...
Champions Oncology Annual Report 2023Evelo Biosciences, a clinical-stage biotech firm headquartered in Cambridge, Massachusetts, is dedicated to developing oral medicines that have systemic effects by targeting immune cells in the sma...
Evelo Biosciences, Inc. Annual Report 2021Biopharmaceutical company BioLineRx Ltd. is making waves in the field of oncology with its cutting-edge drug development program. The company's lead candidate, Motixafortide, has completed Phase 3 ...
BioLineRx Ltd. Annual Report 2023ImmuCell Corporation, a prominent animal health developer, manufacturer, and distributor based in Portland, Maine, has expanded its reach beyond the borders of the United States. Its products, whic...
ImmuCell Annual Report 2023La Jolla Pharmaceutical Company is a biopharmaceutical company that specializes in the development of life-saving medicines. Its main focus is on creating therapeutics to treat severe illnesses. Th...
La Jolla Pharmaceutical Company Annual Report 2019Immunic, a clinical-stage biopharmaceutical company, is developing a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its most prom...
Immunic Annual Report 20239 Meters Biopharma, Inc. is making waves in the biopharmaceutical industry with its focus on delivering treatments for rare digestive diseases, gastrointestinal conditions with unmet needs, and deb...
9 Meters Biopharma, Inc. Annual Report 2021Singapore-based ASLAN Pharmaceuticals Limited is a clinical-stage biopharmaceutical company with a focus on immunology, working towards developing treatments that have the potential to significantl...
ASLAN Pharmaceuticals Limited Annual Report 2023Vir Biotechnology, Inc., a cutting-edge immunology firm, is carving out a prominent place in the medical world with its innovative therapeutic products designed to battle severe infectious conditio...
Vir Biotechnology, Inc. Annual Report 2023Marker Therapeutics, Inc., a clinical-stage immunotherapy company, is making strides in the development and commercialization of T cell-based immunotherapies for the treatment of various types of c...
Marker Therapeutics, Inc. Annual Report 2023Rhythm Biosciences Limited is an Australian medical diagnostics company that specializes in developing and commercializing cutting-edge technology for the early detection of colorectal cancer. The ...
Rhythm Biosciences Limited Annual Report 2023